UroAlert - GU Oncology Daily

February 06, 2025

Videos

Peer-to-Peer Clinical Conversations

Consolidative Local Therapy in Metastatic Bladder Cancer After Systemic Treatment Response - Fed Ghali

Fed Ghali

Sam Chang is joined by Fed Ghali to discuss the role of consolidative local therapy in metastatic bladder cancer patients who show robust response to systemic therapy.

Effectiveness of PSMA-Lutetium for Prostate Cancer Liver Metastases - Daniel Childs

Daniel Childs

Daniel Childs discusses real-world outcomes of lutetium-PSMA-617 treatment in prostate cancer patients with liver metastases, based on Mayo Clinic registry data.

Beyond the Abstracts

Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis - Beyond the Abstract

Reflections on the AMBASSADOR Trial: The Role of Adjuvant Pembrolizumab in Muscle-Invasive Urothelial Carcinoma - Beyond the Abstract

Conference Coverage

ASTRO 2024: Pathologic Features of Small Cell Variants of the Genitourinary Tract

ASTRO 2024: Pembrolizumab Monotherapy Following Tri-Modality Treatment for Selected Patients with Muscle-Invasive Bladder Cancer

ASTRO 2024: Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs IMRT for Localized Prostate Cancer

ASTRO 2024: Role of Brachytherapy for Unfavorable Intermediate Risk Prostate Cancer

ASTRO 2024: Prospective Evaluation of Supplemental External Beam Radiotherapy in Higher Risk Prostate Cancer Patients Implanted with Pd-103: Long-Term Results of the 44/20/0 Trials

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

Impact of late effects after treatment for bladder cancer with radical cystectomy on Quality of life: a case-control study.

Development of point-of-care tests for urinary bladder cancer - an historic review and view to future prospectives.

Assessing the Influence of Smoking on Inflammatory Markers in Bacillus Calmette Guérin Response Among Bladder Cancer Patients: A Novel Machine-Learning Approach - Beyond the Abstract

Renal Cancer

MAPK1IP1L::TFE3-rearranged renal cell carcinoma: a novel fusion adding to the differential diagnosis of oncocytic renal neoplasms.

Diagnostic performance of artificial intelligence in detection of renal cell carcinoma: a systematic review and meta-analysis.

New Mediastinal and Hilar Lymphadenopathy After Adjuvant Pembrolizumab in a Patient With Stage III Clear Cell Renal Cell Carcinoma.

Prostate Cancer

Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer.

Ultra-fast biparametric MRI in prostate cancer assessment: Diagnostic performance and image quality compared to conventional multiparametric MRI.

Refining partial gland ablation for localised prostate cancer: the FALCON project.

Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials.

Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy.

Prognostic Value of MR Visibility/Invisibility in Men on Active Surveillance - Beyond the Abstract

Testicular Cancer

Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2025 Digital Science Press, LLC